Ovid announces positive initial data from ongoing ENDYMION extension trial of soticlestat Sep. 25, 2019
GABA Therapeutics and ATAI Life Sciences to develop GRX-917 for the treatment of mood disorders Sep. 25, 2019
Lenti-D demonstrates the ability to stabilize neurologic disease progression in phase II/III study Sep. 23, 2019
Alzprotect cleared to begin French phase IIa trial of AZP-2006 in progressive supranuclear palsy Sep. 19, 2019
First-in-human study evaluates UB-312 in healthy subjects and patients with Parkinson's disease Sep. 19, 2019
RSS